Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer.
Tay DJT, Song Y, Peng B, Toh TB, Hooi L, Toh DK, Hong H, Tang SJ, Han J, Gan WL, Chan THM, Krishna MS, Patil KM, Maraswami M, Loh TP, Dan YY, Zhou L, Bonney GK, Chow PK, Chen G, Chow EK, Le MTN, Chen L.
Tay DJT, et al. Among authors: peng b.
Mol Ther. 2021 Nov 3;29(11):3258-3273. doi: 10.1016/j.ymthe.2021.05.008. Epub 2021 May 8.
Mol Ther. 2021.
PMID: 33974998
Free PMC article.